Neuroimaging placebo effects: New tools generate new questions

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 4, 2009, Pages 352-354

  Jarcho, J M ^a   Mayer, E A ^a   London, E D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARFENTANYL C 11; FLUORODEOXYGLUCOSE F 18; NEUROTRANSMITTER; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WATER O 15;

BEHAVIOR; BRAIN FUNCTION; BRAIN REGION; BRAIN SCINTISCANNING; HUMAN; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACEBO EFFECT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY;

BRAIN; CEREBROVASCULAR CIRCULATION; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; PLACEBO EFFECT; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID, MU;

EID: 70349440705     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.126     Document Type: Short Survey

References (0)